FindTrial
Sign In

A Study to See How Certain Proteins Are Linked with the Severity of Urinary Bladder Cancer in Patients.

Expression of EGFR [epidermal growth factor receptor] and her2/neu [human epidermal growth factor receptor] in urinary bladder carcinoma and its Association of clinicopathological parameters - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/02/104152
Enrollment
30
Registered
2026-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C679- Malignant neoplasm of bladder, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the newly diagnosed cases of urinary bladder carcinoma whose samples (resected/biopsy)are received in the department of pathology MAMC

Exclusion criteria

Exclusion criteria: Patient who have received radiotherapy and chemotherapy

Design outcomes

Primary

MeasureTime frame
Proportion of case of urinary bladder carcinoma showing EGFR and HER2 neu expressionTimepoint: 1 year—

Secondary

MeasureTime frame
Association between expression of EGFR & HER2 neu with clinicopathological parameterTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Varuna Mallya

Maulana Azad Medical College

varunamallya@gmail.com9599966089

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026